Quantitative glycomics of human whole serum glycoproteins based on the standardized protocol for liberating N-glycans.
about
Recent advances in sialic acid-focused glycomicsPurification of derivatized oligosaccharides by solid phase extraction for glycomic analysisBlotGlycoABCTM, an integrated glycoblotting technique for rapid and large scale clinical glycomics.Functional network of glycan-related molecules: glyco-net in glycoconjugate data bank.Improving N-glycan coverage using HPLC-MS with electrospray ionization at subambient pressure.Recent advances in cellular glycomic analyses.High-mannose glycans are elevated during breast cancer progressionAnalysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2007-2008.High-sensitivity analysis of naturally occurring sugar chains, using a novel fluorescent linker molecule.Glycan analysis by reversible reaction to hydrazide beads and mass spectrometry.The sweet and sour of serological glycoprotein tumor biomarker quantification.Selective isolation and analysis of glycoprotein fractions and their glycomes from hepatocellular carcinoma sera.High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations.Comprehensive Glycomics of a Multistep Human Brain Tumor Model Reveals Specific Glycosylation Patterns Related to MalignancyGlycome characterization of immunoglobulin G from buffalo (Bubalus bubalis) colostrum.Inconsistencies in the red blood cell membrane proteome analysis: generation of a database for research and diagnostic applications.Sialylation determines the nephritogenicity of IgG3 cryoglobulins.Development of a novel system for mass spectrometric analysis of cancer-associated fucosylation in plasma α1-acid glycoproteinQuantitative liquid chromatography-mass spectrometry-multiple reaction monitoring (LC-MS-MRM) analysis of site-specific glycoforms of haptoglobin in liver disease.Glycome profiling using modern glycomics technology: technical aspects and applications.Glycan labeling strategies and their use in identification and quantification.Relative versus absolute quantitation in disease glycomics.Reversed-phase separation methods for glycan analysisQuantitative glycomics using liquid phase separations coupled to mass spectrometry.Automated, high-throughput serum glycoprofiling platform.Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging.Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging.Glycosylation specific for adhesion molecules in epidermis and its receptor revealed by glycoform-focused reverse genomics.Label-free quantitation: a new glycoproteomics approach.Quantitative analysis of total serum glycome in human and mouse.Sulfonyl hydrazine-functionalized polymer as a specific capturer of reducing glycans from complex samples for high-throughput analysis by electrospray ionization mass spectrometry.
P2860
Q26866630-D5316CE6-1F75-487F-A496-149AC006D3E9Q28542008-C1ED6D14-32FB-41B0-9517-7C8A3448AFF4Q33305172-818E5B76-C3B8-402F-914D-F499C7D44BDBQ33452691-C0C2F3C6-E3D9-444A-AC55-1948895116E1Q33456015-A9F1AD9C-2191-4F59-8AD7-20F5795094D6Q33649651-DA45233A-26D9-43D2-A5C2-1D1578DAAE46Q33753523-6476BFE3-6603-484D-9B67-36CCF7A5A592Q33995843-18829564-DF5B-4B41-96D2-F059360D79CDQ34048244-ED1966B6-FC6B-46B2-A9BD-BDE7CCF3DAC0Q34150383-144B06CB-913A-4CF8-86A4-32426BCC8125Q34580285-36BD7A21-FA55-4E86-B8BB-40CD5DCEA098Q34597839-C2BB378D-F1F7-4399-B9BA-8928F40F8306Q35497686-6AD90049-1C3D-4AD2-8407-9EB4F1E4AA6EQ35679876-35458862-B541-4713-83D0-C90E79975209Q35736606-B73FAE22-F0E6-4060-BE8A-62C0B9BD8AA1Q35779119-B7C4D22B-38C5-40CD-8B77-DD47F7188A13Q36352180-BC8A3937-5C98-4F69-BFD8-E5875A8C277AQ36651283-4F1238C0-1C8E-4ADC-9980-817C74E40991Q36832494-887F63D1-FCE4-43B5-AC40-AE98AF8E59CFQ37686527-FBBC317F-6072-4929-850C-2FB008B859CAQ37708129-85703AA6-1E6F-4410-B26B-60A22952FA38Q38356585-C4D078EB-62A5-49C4-A0A4-4378A2A4DAE4Q39020352-BD5A67FE-22BD-41A0-BA71-77A2FB902DCAQ39124498-D563EAD7-63EE-4836-9E40-0B26F8923BF5Q40720351-EBBFBA70-B53B-4EF7-A6EF-AE81EF47EB8EQ40744914-909305AB-F980-42D0-A886-5D6DC05713EFQ42181384-AC0C747C-C8AD-4721-992B-169F0ED801D6Q43871500-80209C43-BCF4-49B0-94B3-47EBCDBCDE0FQ46054137-98C85AC4-F15B-4459-B3E8-DF370F326E82Q46465603-BC12DBC8-2C43-470F-92F8-E96212F3457AQ46577977-7DE30B6C-F25D-4F5E-B1BB-43556B88B3E0
P2860
Quantitative glycomics of human whole serum glycoproteins based on the standardized protocol for liberating N-glycans.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Quantitative glycomics of huma ...... ocol for liberating N-glycans.
@ast
Quantitative glycomics of huma ...... ocol for liberating N-glycans.
@en
Quantitative glycomics of huma ...... ocol for liberating N-glycans.
@nl
type
label
Quantitative glycomics of huma ...... ocol for liberating N-glycans.
@ast
Quantitative glycomics of huma ...... ocol for liberating N-glycans.
@en
Quantitative glycomics of huma ...... ocol for liberating N-glycans.
@nl
prefLabel
Quantitative glycomics of huma ...... ocol for liberating N-glycans.
@ast
Quantitative glycomics of huma ...... ocol for liberating N-glycans.
@en
Quantitative glycomics of huma ...... ocol for liberating N-glycans.
@nl
P2093
P2860
P1476
Quantitative glycomics of huma ...... ocol for liberating N-glycans.
@en
P2093
Akio Takimoto
Jun-ichi Furukawa
Masahiro Ohno
Mika Nakano
Shin-Ichiro Nishimura
Yasuro Shinohara
Yoshiaki Miura
P2860
P304
P356
10.1074/MCP.T600063-MCP200
P577
2007-05-23T00:00:00Z